Dry Eye Symptoms Clinical Trial
Official title:
Dry Eye Symptoms of University Students Under China's Dynamic COVID-zero Strategy: A Comparison Between the Epidemic and Non-epidemic Areas
| NCT number | NCT05476068 |
| Other study ID # | [2022]NO.(001). |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | March 20, 2022 |
| Est. completion date | May 25, 2022 |
| Verified date | July 2022 |
| Source | Second Affiliated Hospital of Nanchang University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
To compare the prevalence of dry eye symptoms and to investigate the association of the risk factors with the dry eye symptomatology among university students in the epidemic and non-epidemic areas of China under the COVID-zero strategy.
| Status | Completed |
| Enrollment | 1807 |
| Est. completion date | May 25, 2022 |
| Est. primary completion date | May 20, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 45 Years |
| Eligibility | Inclusion criteria: - College students with age =18 years - No other medication history in recent 2 weeks; - Have high compliance and are willing to fill in the questionnaire on time Exclusion criteria: - routinely using artificial tears and Other eye drops; - taking any medication that could interfere with the results of the study; - with any history of eye surgery |
| Country | Name | City | State |
|---|---|---|---|
| China | The Second Affiliated Hospital of Nanchang University | Nanchang | Jiangxi |
| Lead Sponsor | Collaborator |
|---|---|
| Yifeng Yu |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | A score of ocular surface disease index (OSDI)questionnaire | Ocular surface disease index (OSDI)questionnaire : (1) OSDI: =12 (no DED symptoms), 13 = d = 22 (mild DED symptoms), 23 = d = 32 (moderate DED symptoms), and =33 (severe DED symptoms). | DAY 0 | |
| Primary | A score of GAD-7 questionnaire | GAD-7 questionnaire: (1) 0 < GAD-7 = 4 (normal), 5 = GAD-7 = 9 (mild anxiety), 10 = GAD-7 = 13 (moderate anxiety), 14 = GAD-7 = 18 (moderate and severe anxiety), and 19 = GAD-7 = 21 (severe anxiety). | DAY 0 | |
| Primary | A score of PHQ-9 questionnaire | PHQ-9 questionnaire: (1) 0 < PHQ-9 = 4 (normal), 5 = GAD-7 = 9 (mild depression), 10 = GAD-7 = 14 (moderate depression), 15 = GAD-7 = 19 (moderate and severe depression), and 20 = GAD-7 = 27 (severe depression). | DAY 0 | |
| Secondary | A score of UCLA Loneliness Scale questionnaire | UCLA Loneliness Scale Questionnaire: (1) UCLA < 28 (low loneliness), 28 = UCLA = 33 (generally lower), 33 < UCLA = 39 (intermediate level), 39 < UCLA = 44 (generally higher), and GAD-7 > 44 (highly lonely). | DAY 0 | |
| Secondary | Students' increased use of mobile phones | Students choose to increase the time of using mobile phones according to options: 0 hours, less than 1 hour, 1-3 hours, 3-5 hours, 5-7 hours, and more than 7 hours | DAY 0 | |
| Secondary | Frequency of student sports | Students choose the frequency of sports according to the options, which are: less than once a month, 2-3 times a month, 1-2 times a week, 3-5 times a week, and once a day. | DAY 0 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00938951 -
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
|
N/A |